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Background: Being an intermediate stage in the development of diabetes, pre-diabetics were estimated as high as
14% to 63% in China and one to three quarters of them will develop into diabetes within 10 years. It is well
established that the risk of diabetes progression can be modified substantially and a whole range of proven
guidelines, protocols and methodologies are available. Unfortunately, most proven interventions are seldom used in
daily practice and this is especially true in resource poor rural China. This project aims at demonstrating that an
evolutionary intervention package featuring low cost, integration with routine services, cultural sensitization and
self-optimization, is effective and sustainable in preventing diabetes.
Methods/design: This project utilizes a quasi cluster randomized controlled trial and a batched implementation
strategy in which villages are recruited in 7 blocks within 7 consecutive years respectively. Block 0 involves 3
villages and provides an opportunity for piloting and refining primitive intervention methodologies and protocols.
The following 6 blocks consist of 14 villages each and serve as intervention arm; while all the villages not yet
started intervention form the control arm. For each block, measurement happens at baseline and every 12 months
(for plasma glucose) or monthly (for body weight and blood pressure) after baseline. These arrangements enable
documentation of up to 6 years of consecutive measures and detection of lower incidence of progression into
diabetes, improved body max index and blood pressure, and increased service use and involvement in healthy
dietary and physical activities among pre-diabetics receiving the experimental intervention compared to themselves
at baseline or those in the delayed-intervention control condition.
Discussion: China has a long history of separating disease prevention and treatment systems and there is a clear
need to leverages key success factors in a synergetic way toward integrated and sustainable diabetes prevention.
This project is owned and managed by local health authorities and utilizes available resources. It introduces a
package of long-term incentives, establishes ongoing mechanisms for continuous capacity building and quality
improvement, and builds up an operational cycle for catalyzing similar efforts in the local prefecture even
throughout rural China.
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Type 2 diabetes mellitus (hereafter referred to as diabetes)
has been increasing relentlessly since the second half of the
20th century [1-3]. Over 10% of adults are suffering from
the diseases in economically affluent counties, e.g., Saudi
Arabia, the USA, Switzerland and Austria. More import-
antly, the pandemic is increasing and expanding rapidly
from affecting primarily the developed nations to afflicting
also the developing world. Predicted diabetes will claim up
to 366 million people worldwide by 2030 [2]. It was be-
lieved that diabetes prevalence is relatively low in China
[1]. Yet a recent nationwide investigation revealed that
age-standardized prevalence of total diabetes in China is
also as alarmingly high as 9.7% with about 3% difference
between urban and rural residents (11.4% vs. 8.2%) [4].
And it was predicted that the number of patients with dia-
betes in China will double by 2030 [2]. Diabetes inter-
acts with other major risk factors (e.g., hypertension,
dyslipidemia) and increases the risk of a variety of morbid-
ities (e.g., chronic kidney disease, end-stage renal disease,
atherosclerosis, coronary heart disease and cerebral ische-
mia) leading to tremendous physical, psychological and
socioeconomic sufferings and burdens [5].
Pre-diabetes, a lesser degree of hyperglycemia, repre-
sents an intermediate stage in the development of diabetes
[6,7]. One to three quarters of pre-diabetes develop into
diabetes within 10 years of detection [8]. Prevalence of
pre-diabetes was estimated at from 10% to 30% worldwide
and 14% to 63% in China [4,9,10]. This prevalence rate is
closely linked to age, obesity, family diabetes history etc.
[4,11-13]. It is well established that the risk of diabetes
progression can be modified substantially (by 20 to 60%)
regardless of nation and population groups [14-16]. Our
systematic literature review identified 26 randomized con-
trolled trials (RCTs) on diabetes prevention in China
which also documented over 45% diabetes progression re-
duction [17-42]. Although the precise mechanism linking
pre-diabetes and diabetes is not completely known, com-
monly recognized factors influencing the progression in-
clude age, obesity, physical inactivity, hyperinsulinemia,
insulin resistance etc. [8]. So, existing interventions pre-
venting diabetes evolve along three major lines, namely
physical activities promotion, dietary modification and
glucose-lowering medication. In the 26 RCTs carried out
in China, medication was used in 11 and not in 15. Results
in reducing progression were no better with medication.
And this is consistent with most researches in other coun-
tries [14-16]. Screening has always been an integral part
of interventions against progression from pre-diabetes
to diabetes being used to identify priority groups to le-
verage lifestyle modification and compliance with in-
terventions [10]. In addition, quite a few articles
documented successful application of modern informa-
tion technologies in diabetes prevention and treatment[43]. Encouraged by high efficacies, tremendous efforts
have been invested in this regard and a whole range of
IECs, guidelines, protocols, tool kits and best practices
are available [44].
Unfortunately, most proven interventions are not being
fully used in daily diabetes prevention. This is especially
true in resource poor rural China where over 75% of the
nation’s vast population lives. None of the above men-
tioned 26 RCTs was launched in rural China. Published
and our own preliminary investigations all suggest that
rural village doctors seldom involve in diabetes identifica-
tion and prevention [45,46]. As a result, 42.34% to 81.82%
of rural villagers newly screened with diabetes had never
been diagnosed as having the disease before [47]. Know-
ledge about diabetes among rural villagers, especially the
elder villagers, was extremely low [48]. A variety of factors
may be attributed to this huge gap between proven tech-
nologies and application. Firstly, China rural village doc-
tors lack necessary knowledge and skills [49]. Less than
12% of them had ever received formal training on and
knew only 43% of basic knowledge about diabetes preven-
tion [50]. Secondly, China rural communities entail vari-
ous values, norms and costumes that are counteractive to
diabetes prevention, e.g., always provide more food than
need for guests, drink the most to show friendship, behave
quiet to respect others etc. [51,52]. Thirdly, China health
system lacks necessary incentives. For example, in Anhui
province, only doctors at township or higher levels are
allowed to prescribe oral medication or insulin for the
treatment of diabetes while village clinic doctors cannot
do so. This removal of responsibility for diabetic care also
decreases incentives for the village clinic doctors, as the
primary caregivers, to be fully alert to the presence of dia-
betes among their patients or to intervene persistently in
those at high risk.
Aim/objectives
This project aims at devising and demonstrating that an
evolutionary intervention package featuring low cost, in-
tegration with routine services, cultural sensitization and
self-optimization, is effective in preventing diabetes and
pre-diabetics receiving the experimental intervention
will, compared to themselves at baseline and pre-
diabetics in the delayed-intervention control condition
show a lower incidence of progression into diabetes, de-
creased body max index (BMI) and blood pressure, and
increased service use and involvement in healthy dietary
and physical activities at follow-up. More specifically,
the first objective is to devise, implement and evaluate
an intervention to reduce progression from pre-diabetes
to diabetes among men and women aged 40 years and
over (hereafter referred to as 40+) living in rural Anhui.
A secondary objective is to establish a sustainable mech-
anism, in which participating village doctors maintain
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with routine medical service ever since initiation of this
project and non-participating village doctors have ready
mechanisms to learn and joint the project in the future.
Methods/design
Project design
This project utilizes a quasi cluster randomized controlled
trial using “administrative” villages (referred to as villages)
as study units and a batched implementation strategies in
which villages are recruited in 7 blocks within 7 consecu-
tive years respectively (Table 1). Block 0 involves 3 villages
and provides an opportunity for piloting and refining
primitive intervention methodologies and protocols. The
following 6 blocks consist of 14 villages each and serve as
intervention arm; while all the villages not yet started
intervention form the control arm. For each block, meas-
urement happens at baseline and every 12 months (for
plasma glucose) or monthly (for body weight and blood
pressure) after baseline. These arrangements enable docu-
mentation of up to 6 years of consecutive measures for
both intervention and non-intervention villages and thus
allow for detection of a variety of short to mid-term inter-
vention effects described later in the project monitoring
and evaluation (M&E) section and build a block by block
feedback and refinement cycle.
Selection of participants
This project is supported and implemented in Lu’an, one
of the largest prefectures in An’hui province. It has 7
counties consisting of 156 townships and 2081 “adminis-
trative” villages. The 3 villages included in block 0 were
determined upon convenience considerations; while selec-
tion of villages into all the remaining blocks employs clus-
ter randomization. More specifically, for each block, 2
villages from each of the 7 existing counties of Lu’an are
randomly selected from the complete name list of non-
intervention villages of each of the counties. In order to
avoid potential contamination, all non-intervention vil-
lages with insufficient distance (less than half day walking)Table 1 Block-wise villages in intervention years
Blocks Participating
Year1 Year 2 Year 3







Total villages 3 17 31to existing intervention villages are excluded from the
name list before any new round randomized selection.
Men and women who are 40 and live in the selected vil-
lages for over 6 months per year are all eligible for baseline
and biannual follow up screening. Those who meet pre-
diabetics but exclusion criteria are treated as priority inter-
vention group. Pre-diabetics are defined as villagers with a
fasting glucose 5.6 < 6.9 mmol/l who are not currently be-
ing treated with oral hypoglycemic medication or insulin.
Those with baseline fasting glucose 6.1-6.9 mmol/l but are
confirmed by higher level hospital as diabetic and those
with a fasting glucose 5.6-6.9 mmol/L but are on treat-
ment with oral hypoglycemic medication or insulin are ex-
cluded from the priority intervention group.
All the accredited village doctors from the clinics of
the selected villages are encouraged to participate.
Intervention elements
Given that this project encourages continuous improve-
ment, intervention details may vary from village to village
and from time to time. However, key elements of interven-
tion are summarized as eCROPS in which e, C, R, O, P
and S stands for educating doctors and electronic sup-
ports, counseling diabetes prevention, recipe for lifestyle
modification, operational toolkit, performance-based re-
imbursement for doctors and screening service respect-
ively (see Figure 1).
Counseling diabetes prevention (C) is delivered by
village doctors at village clinics and comprises four kinds
of sessions: a) counseling glucose screening applies to
40+ villagers not yet diagnosed with pre-diabetes or dia-
betes and aims at promoting participation in baseline
and biannual follow up glucose screening; b) counseling
referrals targets suspected diabetics (fasting glucose >6.1
mmol/l) and urges and helps them to seek higher level
diabetes service; c) counseling behavior change planning
pertains to newly diagnosed pre-diabetics and uses the
newly diagnosed pre-diabetic condition as a powerful
trigger to leverage and plan lifestyle changes; d) counsel-
ing behavior reinforcement and problem solving starts,villages by implementation years
Year 4 Year 5 Year 6 Year 7
3 3 3 3
14 14 14 14
14 14 14 14




45 59 73 87
Figure 1 Key components of project intervention (eCROPS).
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on behavior change planning at a monthly (in the first
year) and bimonthly (in the second year) and quarterly
base (in the remaining years) and focuses on reinforcing
behavior improvement and solving barriers to behavior
changes. All counseling sessions utilizes standard oper-
ation procedure (SOP) developed on base of published
protocols [53] and tailored via rounds of consensus ex-
pert group activities to ensure delivery of minimum key
elements, though the counselor village doctors are en-
couraged to make the best use of their own experiences.
Recipe for lifestyle changes (R) is a user-friendly
“educational wall calendar” for promoting diabetes-
related lifestyle modifications. The calendar consists of
12 pages (one for each month). A typical calendar page
has 4 pictorial components. On top of the page, is the
theme component portraying the key approach and ul-
timate goal of this project, i.e., “balanced diet and ad-
equate activity improves health and happiness”. The
remaining components appear in 3 columns beneath the
theme. The left and right column depicts monthly set of
tips on how to archive balanced diet and maintain ad-
equate daily physical activity respectively. The middle
column divides into 49 cells (7 rows*7columns) each fills
with a food picture as background. The top and bottom
8 to 13 of these cells are marked with red “no-parking
symbol” on top of food pictures meaning that the foods
shown by the background pictures damage health and
cause diabetes; while the middle 28 to 31 cells are
printed with numbers on top of the colored food pic-
tures indicating, in addition to dates in the correspond-
ing month, that the foods shown in these cells are
healthy and help prevent diabetes. Although all thecalendar pages share these common components, they
differ in color mix, in specific items of recommended
and warned foods, and in detailed tips on diet activity
changes.
Operational toolkit (O) gears with a workbook, a
manual and a set of cue-cards. The workbook serves as
a means for recording minimum information (e.g., date,
patient’s name, blood sugar test result, weighing result,
summary of counseling, start and end time of the ser-
vice) about diabetes prevention service delivered by vil-
lage doctors on encounter by encounter base. The cue-
cards are designed to help delivery of key counseling
components. In order to facilitate fast selection, the cue-
cards are printed in blue, red, yellow and green applying
for the four types of counseling mentioned above re-
spectively. Each card enlists critical steps or elements for
delivering a specific type of counseling. For example, the
yellow card on counseling behavior change planning re-
minds the following key points: a) trust building; b) im-
plications of pre-diabetic status, its link to diabetes, the
seriousness of diabetes; c) the need for immediate life-
style changes; d) efficacies of lifestyle modifications in
preventing progression to diabetes; e) plans to change
current dietary and physical habits; f ) potential barriers
to planned dietary and physical activity changes; g) roles
of the pre-diabetic and his or her family members play
in implementing the planned changes. The manual is a 3
part user-friendly reference book for village doctors. Part
A, elementary protocols, entails step by step SOPs for
executing essential prevention tasks, e.g., performing
diabetes screening, counseling dietary modification,
counseling physical activity planning etc. Part B, com-
mon problems and solution tips, gives dos and don’ts to
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counter in delivering diabetes interventions, e.g., brea-
ches to planned diet, increasing BMI, failed follow ups,
failed attempts refusing over eating at social events etc.
Part C, fundamentals of diabetes prevention, provides
basic knowledge for effective intervention execution,
e.g., pathology of diabetes, counseling principles and
techniques, diabetes screening and treatment, socio-
cultural aspects of diabetes etc.
Performance-based incentives (P) apply to village
doctors and include prevention requirement, financial
reimbursement, honor awarding, and membership of In-
tegrated Service Network (ISN). Firstly, the local health
authority has issued a policy mandating that all prac-
ticing village doctors must deliver a minimum of preven-
tion service so as to qualify future license renewal and
participation in diabetes prevention gains required pre-
vention credits. Secondly, diabetes prevention is finan-
cially reimbursed upon service volume and quality.
Thirdly, each participating village doctor meeting a
minimum of diabetes prevention standard will be pub-
licly awarded an honor called Integrative Service Pro-
vider (ISP). Fourthly, participation in eCROPS qualifies
membership of the ISN that enjoys a) free access to peri-
odical circulation of ISN Newsletter and a web-based
forum for sharing cases and experiences maintained by
ISN members; b) free enrollment in educational pro-
grams offered by ISN that satisfy annual continuing edu-
cation credits requirement mandated by the local health
authorities; c) technical assistance from higher level ISN
members including members from township health cen-
ters and county, prefecture and province level hospitals;
d) dual referral privilege within the ISN. All these incen-
tives are based on performance indicators including
mainly plasma glucose, BMI and blood pressure control,
and compliance with diet and physical activity plans etc.
Screening service (S) consists of extended and fo-
cused screening and counseling anchored to the screen-
ing. Extended screening occurs biannually and covers all
villagers aged 40+ but includes only blood sugar testing;
while focused screening centers on identified pre-
diabetics and includes annual blood sugar and monthly
(or bimonthly or quarterly) body weight and blood pres-
sure measurement. These periodical screenings play a
key role in leveraging desirable dietary and physical be-
havior changes for villagers view blood glucose tests,
BMI and blood pressure measures as scientific, powerful
and convincing. Higher- than-normal results are used to
highlight the importance of persistent lifestyle modifica-
tion. Improving measures are feedback to re-enforce
constructive actions already taken by the pre-diabetics.
While worsening findings serve as a trigger for looking
for and solving potential problems and for promoting
more rigorous efforts in dietary and physical activity.Electronic supports (e) comprise web-based (built on
an ASP.NET plus SQL2008 platform) and user-friendly
preventive case management system (PCMS), technical
assistance (TA), and monitoring and evaluation support
(MES). The PCMS supports village doctors in: a)
maintaining a dataset of villagers aged 40+ and partici-
pating pre-diabetics; b) scheduling screening and coun-
seling services; c) notifying and reminding (via land or
cell-phone) individual villagers about time to attend
counseling, weigh-in etc.; d) reviewing performance and
intervention history of individual and group pre-
diabetics; e) guiding (via built-in standard operating pro-
cedures) delivery of major intervention activities e.g.,
counseling, problem solving etc.; f ) entering minimum
dataset required by project M&E. The TA for village
doctors takes the forms of: a) web-based tutorial on
implementing the project prevention in both video and
textile formats; b) case studies in which participating vil-
lage doctors are requested to record and post at least
10% of bottom cases (in terms of compliance with
planned lifestyle changes, glucose and BMI control etc.)
on the ISN Web-Forum and then experts and other vil-
lage doctors within the ISN discuss and share experi-
ences coping with similar cases; c) video and pictorial
materials about diabetes and its prevention suitable for
displaying at village clinics for attending pre-diabetics.
The MES is designed for project managers to: a) solicit
minimum dataset for project M&E; b) track aggregate
and individual deviation from planned objectives and de-
liverables; c) feedback M&E findings.
Monitoring and evaluation
The project also emphasizes rigorous yet sustainable
M&E closely intertwined with routine prevention ser-
vices in which data for M&E come mainly from daily
service records and findings of M&E are used primarily
for improving diabetes prevention.
Indicators for M&E divide into four categories, namely,
socio-demographic characteristics, intervention compli-
ance, equipment measures, and indicator attention score
(IAS). Social demographic variables cover age, gender, eth-
nicity, migration patterns, marital status, education, family
income, household membership. Intervention compliance
includes: a) the proportion of 40+ year olds who report for
screening; b) the proportion of those identified as pre-
diabetic who attend at least 10 counseling sessions in the
first year of the intervention; and c) the proportion of vil-
lage clinic doctors who complete the counseling sessions
assigned. Equipment measures comprise random and
fasting capillary glucose, BMI, systolic blood pressure
(SBP) and diastolic blood pressure (DBP). An IAS of a spe-
cific village doctor ranges from 0 through to 10 meaning
his or her measurement of M&E indicators merits least
(IAS=0) to most (IAS=10) attention. It is a composite
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tween the “test-retest” findings by the village doctor and a
CDC staff separately; b) deviations of last time M&E mea-
sures by the village doctor from mean measurements by
all village doctors in the same block at the same time
point; c) variations in same M&E indicator measured by
the same village doctor at the last two time points as com-
pared with that of other village doctors in the same block.
Time points for data collection depend on indicator
and subjects to be assessed. Random glucose measure-
ment happens at baseline and every two years after
intervention initiation in any block for all villagers aged
40+ yet not diagnosed with diabetes or pre-diabetes;
while fasting glucose testing occurs at baseline and every
year thereafter but covering only participating pre-
diabetics or suspected pre-diabetics. SBP/DBP and body
weight measurement takes place for all 40+ year partici-
pant villagers at baseline and monthly in first year, bi-
monthly in the second year, and quarterly in the
remaining years. Intervention compliance data come
from ad hoc prevention service records and data about
socio-demographics of pre-diabetes are collected at
baseline and renewed annually if necessary. These data






Figure 2 Expected outcome indicator changes. Legend: (a) expected ac
years; (b) expected weight changes in different blocks and years; (c) expec
diastolic blood pressure changes by blocks and years.into an online project database by the corresponding vil-
lage doctors within one week after service delivery. Ran-
dom “retests” happen at non-fixed-time decided by local
CDC staff every year.
Statistical analysis centers on two key stakeholders,
i.e., managers and researchers, and participating village
doctors. Analysis for the former comprises of two steps.
Initial analysis consists of descriptive summaries intended
to examine major project deliverables and patterns of the
various measurements (Figure 2) and check for normality
of the continuous variables. And necessary transforma-
tions are explored and selected, if necessary, to induce ap-
proximate normality. The next step analyses estimates,
using two-sided test of the null hypothesis, of the power
of differences between the intervention and delayed inter-
vention groups and between different time points in terms
of diabetes prevalence rates, accumulated progression
rates from pre-diabetics to diabetics, plasma glucose
levels, SBP/DBP, BMI, and intervention compliance indi-
cators. For village doctors, analysis produces: a) pre-
diabetic specific outcome plots showing the trend in the
aforementioned outcome indicators (FPG, BMI, DBP,
SBP) compared with that of the normal group (Figure 3);
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cumulative survival free of diabetes by implementation blocks and
ted systolic blood pressure changes by blocks and years; (d) expected
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participating pre-diabetics within specific villages con-
trasted with that of all the pre-diabetics in the villages of
the same block; c) doctor specific IAS and ranges of top
and bottom 25% IASs among all participating village
doctors.
Use of M&E findings serves two closely interrelated
purposes, i.e., improving project prevention service and
data quality, via a combination of strategies. Firstly, the
pre-diabetic specific outcome plots are feedback, on an ad
hoc base and via the PCMS, to corresponding village doc-
tors to help them to: a) demonstrate and re-enforce pro-
gress made; b) alert lagging behind and leverage more
rigorous lifestyle changes; c) identify “difficult” pre-
diabetics and set priority intervention targets. Secondly,
the village specific performance plots, the IASs and IAS
ranges are forwarded twice a year to related village doctors
to: a) inform performance achievement compared with
peer village doctors so as to generate momentum to main-
tain or improve performance; b) explore barriers and so-
lutions to higher performance by tracing the lowest
performance indicators; c) warn added attention to M&E
indicator measurement if the IAS is too high (e.g., greater
than that of the top 25 percentile). The project efficacy as
well as deliverables, village doctor specific performance
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Figure 3 Example pre-diabetics specific outcome plot. legend: in (a), re
pre-diabetes and normal and blue line presents individualized fasting gluco
overweight and normal, green line divides normal and underweight and b
divides hypertension and normal blood pressure, green line divides norma
individualized blood pressure.management and related CDCs and policy makers to:
a) judge overall project progress and insure fulfillment
of project milestones and objectives; b) estimate
performance-based awards to village doctors; c)arrange
additional technical support to poor performer doctors;
d) prioritize village doctors (e.g., doctors with bottom
25% IASs) for intensified re-assessment of M&E indi-
cators; e)obtain additional support and adjust the
performance-based incentives; f ) decide upon project
value, continuation, expansion or termination.
Discussion
Given that China has a long history of separating disease
prevention and treatment systems [54], there is a clear
need to enhance the health care infrastructure and to
teach providers how to help individuals at risk prevent
diabetes. The need appears to be most urgent in rural
areas, where 75% of the population lives yet lack appro-
priate resources for curbing the fast growing epidemic.
This project strives to tackle a series of barriers to in-
corporating diabetes intervention, especially behavioral
modification with routine medical services. Although
with minimum technical support from a research group,
this project is owned and managed by local health au-
thorities and utilizes available resources from existing
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d line divides pre-diabetes and diabetes, green line divides
se; in (b), red line divides obese and overweight, orange line divides
lue line presents individualized body weight; in (c) and (d), red line
l blood pressure and hypotension and blue lines presents
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able in almost all aspects and avoids transfer, after pro-
ject termination, of ownership, capabilities, data etc.
More importantly, this project introduces a package of
long-term incentives and establishes an ongoing mech-
anism for continuous capacity building within existing
system. These should greatly enhance project sustain-
ability, which is the key to long-term success since dia-
betes prevention and harm reduction requires lifetime
persistence on healthy diet and elevated physical activ-
ities. The project also builds up, via the block by block
expansion of intervention villages, an operational cycle
for catalyzing similar efforts in the local prefecture even
throughout rural China.
The second feature of this project worth noting refers
to its reliance on village doctors who assume the bulk of
project intervention. The large number of village doctors
(over one million) in China provides enormous potential
for reaching far and wide [55]. As mentioned at the be-
ginning, most village doctors are currently unaware of
and certainly not practicing in diabetes prevention [54].
China’s CDC system is staffed with only 190,000 health
workers, of whom fewer than 5% belong to the chronic
disease prevention taskforce [56]. This project plans to
motivate village doctors to work on diabetes prevention
for only about 15 minutes per day on average. Even so, if
fully implemented in China, this will assume a workload
of over 55,000 full-time preventive health workers, over
6 times that of existing taskforce for whole chronic dis-
eases (diabetes is only one among them) prevention in
China. There are reasons to believe that village doctors
are the best choice for leveraging diabetes prevention for
rural villagers. The historical, social and cultural role of
village doctors provides necessary professional legitim-
acy. Chinese people hold strong beliefs that: a) physi-
cians (including village doctors) are respected and
trustworthy because they save lives; b) patients should
provide their physicians with complete (including confi-
dential) information, for it is in the patient’s own best
interest; and c) the human body is complex and patients
should take their physicians’ advice as their physicians
are educated and experienced in dealing with complex
health problems [57]. In addition, village clinics provide
an ideal context for diabetes intervention. The physical
settings of clinical care are already appropriate for, or can
be easily changed to suit, diabetes measurement and coun-
seling. Since most project prevention service can be ar-
ranged to coincide routine medical care, the timing of
intervention is also important since a patient sees his/her
physician only when he/she is ill. This provides a unique
teaching moment when health is valued and help from
physicians is most needed [58]. Putting together, these can
leverage highly effective interventions. Village doctors’
professional knowledge and experience can again greatlyfacilitate their involvement in diabetes intervention. A
minimal amount of training can produce highly effective
diabetes interventionists.
Thirdly, this project also relies heavily on electronic sup-
ports ranging from telephone messages and educational
web pages to computerized case management systems. Al-
though computers and internet are available at almost all
village clinics and most village doctors have elementary
computer literacy, there are considerable fears about the
ability of village doctors and 40+ villagers in rural China to
use computerized systems. Therefore, this project empha-
sizes that each electronic application brings clear added
value. For example, the use of web-based training and tech-
nical assistance is justified by: a) it saves huge costs com-
pared with traditional training that requires vast village
doctors to leave their practices and convey to training facil-
ities from remote rural areas; b) it gives trainees maximum
flexibility in choosing training time, pace, format etc.; c) it
makes experience sharing an instant access between village
doctors working faraway; d) it allows continuous and limit-
less expansion of trainees; e) through appropriate use of
multi-media techniques, e.g., videos and adequate real word
piloting, web-based training could be made as effective (if
not more effective) as traditional means at a cost much less
than that it saves from traditional training.
Fourthly, this project stresses M&E guided continuous
improvement. Any project, whatever the design, without
adequate M&E is doomed to fail. In this project, M&E
informs almost all key decisions ranging from pre-
diabetics’ efforts on lifestyle modifications at the bottom
to village doctors’ performances in the middle as well as
structural changes and project adjustment on the top.
The M&E employs the simplest indicators (only six) and
measures incurring almost no pain and the least cost for
both service providers and receivers. Most importantly,
all the indicators are closely linked to the outcomes
(health) of the pre-diabetics on one hand and the per-
formance of the village doctors on the other. This clear
relationship makes the project M&E most convincing
for all stakeholders. The majority of M&E data derive
from records of routine prevention by village doctors.
This saves measurement costs and enhances seriousness
about data recording but also raises concerns about con-
flict of interests since recording poor cases may result in
poorer performance assessment. This conflict is resolved
via two mechanisms: a) M&E findings are also used to
inform prevention work and accurately recording FPG,
BMI etc. helps village doctors in identifying and address-
ing service weaknesses; b) the minimum random retests
and statistical checks will detect data fidelity problems.
Finally, this project leverages key success factors in a syn-
ergetic way toward cost- effectiveness and long-term sus-
tainability. For a comprehensive project like this, it is
impossible to distinguish the effects of any specific elements
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selecting and combining elements into a working package
become vital yet challenging. This project tackles this issue
via four major strategies, namely, selection guidance, con-
text tailoring, scrutiny criteria, and soft-systems thinking.
In this project, evidences and/or theories guide selection
of intervention measures. For example, inclusion of coun-
seling lifestyle changes is based on its efficacy evidences
from literature review and design of counseling SOP fol-
lows health belief model and motivational interviewing
[53,59]. The project targets villagers living in rural China
where characterizes strong socio-cultural values and cus-
toms and poor resources, capabilities, accessibilities. Tai-
loring means modifying intervention measures derived
from literature and theories according to these local con-
textual factors. The wall calendar, plots, cue-cards, video
format tutorial all result from contextual sensitizations.
The project aims at effective, low cost and sustainable in-
terventions and all elements included in the intervention
package are subject to rigorous scrutiny against these cri-
teria. The SOPs, for instance, are used on the consider-
ation that they help in ensuring delivery of key contents or
steps of prevention service (and hence increase efficacy)
and in simplifying service procedures (and hence reduce
service delivery and training costs). Soft systems thinking
originates from computer system development and views
all the elements involved in an interactive and holistic
way. Taking the example of random retests for ensuring
M&E measurement reliability discussed above, it is added
to prevent potential morale risks introduced by the inter-
action between the performance-based incentives and
using routine service records as data source for perform-
ance appraisal.Human subject protection
This project involves recruitment, intervention and as-
sessment of villagers and village doctors. So it adheres to
rigorous human subject protection principles and proce-
dures. The study protocol had been reviewed and ap-
proved by the Biomedical Ethics Committee of Anhui
Medical University. Participation of villagers and village
doctors are 100% voluntary. And written informed con-
sent is sought from all participants.Competing interests
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